WordNet
- of or relating to or inside the intestines; "intestinal disease" (同)enteric, enteral
- (microbiology) single-celled or noncellular spherical or spiral or rod-shaped organisms lacking chlorophyll that reproduce by fission; important as pathogens and for biochemical properties; taxonomy is difficult; often considered to be plants (同)bacterium
- relating to or caused by bacteria; "bacterial infection"
PrepTutorEJDIC
- 腸[内]の
- 『バクテリア』,細菌
- バクテリアの,細菌の
- (ある地方・時代の)植物群(相),全植物
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
- 1. 小腸内細菌過剰繁殖の治療 treatment of small intestinal bacterial overgrowth
- 2. 嚢胞性線維症：消化器疾患の概要 cystic fibrosis overview of gastrointestinal disease
- 3. 小腸内細菌過剰繁殖の病因および発症機序 etiology and pathogenesis of small intestinal bacterial overgrowth
- 4. 嫌気性細菌感染 anaerobic bacterial infections
- 5. 成人における特発性細菌性腹膜炎：診断 spontaneous bacterial peritonitis in adults diagnosis
English Journal
- Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in rats.
- Xu D1, Gao J1, Gillilland M 3rd1, Wu X1, Song I1, Kao JY1, Owyang C2.Author information 1Gastroenterology Research Unit, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan.2Gastroenterology Research Unit, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan. Electronic address: cowyang@med.umich.edu.AbstractBACKGROUND & AIMS: Rifaximin is used to treat patients with functional gastrointestinal disorders, but little is known about its therapeutic mechanism. We propose that rifaximin modulates the ileal bacterial community, reduces subclinical inflammation of the intestinal mucosa, and improves gut barrier function to reduce visceral hypersensitivity.
- Gastroenterology.Gastroenterology.2014 Feb;146(2):484-496.e4. doi: 10.1053/j.gastro.2013.10.026. Epub 2013 Oct 22.
- BACKGROUND & AIMS: Rifaximin is used to treat patients with functional gastrointestinal disorders, but little is known about its therapeutic mechanism. We propose that rifaximin modulates the ileal bacterial community, reduces subclinical inflammation of the intestinal mucosa, and improves gut b
- PMID 24161699
- Emerging clinical role of pivmecillinam in the treatment of urinary tract infection in the context of multidrug-resistant bacteria.
- Dewar S, Reed LC, Koerner RJ.Author information Department of Microbiology, Sunderland Royal Hospital, Kayll Road, Sunderland SR4 7TP, UK.AbstractThe continuing spread of resistant Gram-negative bacteria is a therapeutic challenge and prudent use of antimicrobials is therefore essential. Urinary tract infections (UTIs), usually due to Gram-negative bacteria, are among the most common infections seen in the community. Moreover, bacterial strains producing extended-spectrum β-lactamases (ESBLs) that are resistant not only to cephalosporins and penicillins, but also to fluoroquinolones and trimethoprim, are becoming more prevalent in the community. This means that oral antibiotic options to treat these infections are limited. The discovery of new drugs to tackle these problems has been difficult and slow paced; it is therefore timely to 'rediscover' the current antibiotics we have available in our clinical formulary, to determine how best they can be used. Pivmecillinam is an oral antibiotic with excellent clinical efficacy in the treatment of uncomplicated UTIs. It has been used extensively in Nordic countries with few problems, but, despite this, it is not widely used in other countries. There is emerging in vitro and in vivo evidence of its activity against ESBL-producing organisms and its synergistic potential with β-lactamase inhibitors. Pivmecillinam is well tolerated with a low side-effect profile. Pivmecillinam also has a minimal effect on the intestinal and vaginal flora of the host; thus, there is a lower rate of selection of resistant bacteria, vaginal candidiasis and, of note, Clostridium difficile.
- The Journal of antimicrobial chemotherapy.J Antimicrob Chemother.2014 Feb;69(2):303-8. doi: 10.1093/jac/dkt368. Epub 2013 Sep 25.
- The continuing spread of resistant Gram-negative bacteria is a therapeutic challenge and prudent use of antimicrobials is therefore essential. Urinary tract infections (UTIs), usually due to Gram-negative bacteria, are among the most common infections seen in the community. Moreover, bacterial strai
- PMID 24068280
- The Differences in Colonic Mucosal Microbiota Between Normal Individual and Colon Cancer Patients by Polymerase Chain Reaction-denaturing Gradient Gel Electrophoresis.
- Huipeng W, Lifeng G, Chuang G, Jiaying Z, Yuankun C.Author information Department of General Surgery, The 5th People's Hospital of Shanghai, Fudan University, Shanghai, China.AbstractOBJECTIVE: The aim of this study was to analyze the differences in the intestinal composition between normal individuals and colon cancer patients.
- Journal of clinical gastroenterology.J Clin Gastroenterol.2014 Feb;48(2):138-44. doi: 10.1097/MCG.0b013e3182a26719.
- OBJECTIVE: The aim of this study was to analyze the differences in the intestinal composition between normal individuals and colon cancer patients.METHODS: To establish the criteria for screening a normal individual for colon cancer, human colonic biopsies were obtained at routine colonoscopy. For p
- PMID 24162169
Japanese Journal
- 米ぬか摂取による整腸作用に関する研究(予備調査) (温故知新プロジェクト)
- 東京家政大学生活科学研究所研究報告 = Bulletin of Research Institute of Domestic Science, Tokyo Kasei University 38, 57-60, 2015-07
- NAID 40020547950
- 口腔内レンサ球菌による多発性肝囊胞感染をきたした維持透析多発性囊胞腎患者の1例
- 日本透析医学会雑誌 48(11), 663-668, 2015
- NAID 130005110597
- 大豆由来の新規成分 "エクオール" の最新知見
- 日本食品科学工学会誌 62(7), 356-363, 2015
- NAID 130005095933
Related Links
- The predominant bacterial flora of humans are shown in Table 1. This table lists only a fraction of the total bacterial species that occur as normal flora of humans. A recent experiment that used 16S RNA probes to survey the diversity ...
- The intestinal microflora is a complex ecosystem containing over 400 bacterial species. Anaerobes outnumber facultative anaerobes. The flora is sparse in the stomach and upper intestine, but luxuriant in the lower bowel.
Related Pictures
★リンクテーブル★
| リンク元 | 「腸内細菌叢」「enterobacterial flora」 |
| 関連記事 | 「intestinal」「bacterial」「flora」「bacterial flora」 |
「腸内細菌叢」
「enterobacterial flora」
「intestinal」
- adj.
- 腸の、腸管の、腸管内の、消化器系の
- 関
- alimentary system、bowel、digestive system、enteric、enteric canal、entero、gastrointestinal、gastrointestinal system、GI、gut、intestinal tract、intestine
「bacterial」
- adj.
- 細菌性の、細菌の、細菌的な
「flora」